These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Search MEDLINE/PubMed

  • Title: Ketazolam once daily for spasticity: double-blind cross-over study.
    Author: Basmajian JV, Shankardass K, Russell D.
    Journal: Arch Phys Med Rehabil; 1986 Aug; 67(8):556-7. PubMed ID: 2874780.
    Abstract:
    This double-blind cross-over study of 14 severely spastic inpatients with chronic multiple sclerosis reveals that once-daily doses of ketazolam, a new drug, are effective in reducing spasticity in a significant proportion of patients without significant side-effects. Added to the similar findings of an earlier double-blind controlled study of divided doses, the results suggest that this special feature of ketazolam provides a unique flexibility that may be exploited in individual cases.
    [Abstract] [Full Text] [Related] [New Search]